Structural characterization of the putative DNA-binding domain of CP2c and its relevance to zinc binding
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
The transcription factor CP2c has been recently validated as an oncogenic protein that can serve as a promising target for anticancer therapy. We have recently documented that a recombinant protein corresponding to the putative DNA-binding region (residues 63-244) of CP2c adopted two different conformers, one of which is dominated by zinc binding. However, in the present study, a longer construct encompassing residues 63-302 appeared to form a single structural domain. This domain could be considered to adopt a functionally relevant fold, as the known specific binding of a dodecapeptide to this protein was evident. Hence, the residues 63-302 region rather than 63-244 can be regarded as a natively folded structural domain of CP2c. In addition, it was confirmed that zinc ions can bind to this putative DNA-binding domain of CP2c, which resulted in reduced stability of the protein. In this context, it is suggested that the mode of action of CP2c would resemble that of tumor suppressor p53.
Abstract
The transcription factor CP2c has been recently validated as an oncogenic protein that can serve as a promising target for anticancer therapy. We have recently documented that a recombinant protein corresponding to the putative DNA-binding region (residues 63-244) of CP2c adopted two different conformers, one of which is dominated by zinc binding. However, in the present study, a longer construct encompassing residues 63-302 appeared to form a single structural domain. This domain could be considered to adopt a functionally relevant fold, as the known specific binding of a dodecapeptide to this protein was evident. Hence, the residues 63-302 region rather than 63-244 can be regarded as a natively folded structural domain of CP2c. In addition, it was confirmed that zinc ions can bind to this putative DNA-binding domain of CP2c, which resulted in reduced stability of the protein. In this context, it is suggested that the mode of action of CP2c would resemble that of tumor suppressor p53.
참고문헌 (16)
- K. M. Barnhart, , Mol. Cell Biol, 8, pp.3215~ (1988)
- H. C. Kang, , FEBS J, 271, pp.1265~ (2005)
- 조구성, "Intrinsically disordered fold of a PIAS1–binding domain of CP2b", Journal of the Korean Magnetic Resonance Society, 18(1), pp.30~35 (2014), 한국자기공명학회[DOI]
- B. K. Yoo, , Proc. Natl. Acad. Sci. USA, 107, pp.8357~ (2010)
- T. J. Grant, , Proc. Natl. Acad. Sci. USA, 109, pp.4503~ (2012)
- P. K. Santhekadur, , Am. J. Cancer Res, 2, pp.269~ (2012)
- Ku-Sung Jo, "Structural assessment of the tetramerization domain and DNA-binding domain of CP2c", Journal of the Korean Magnetic Resonance Society, 22(4), pp.119~124 (2018), 한국자기공명학회[DOI]
- Q. Ming, , Nucleic Acids Res, 46, pp.2082~ (2018)
- 조구성, "Backbone NMR Assignments of a Putative p53-binding Domain of the Mitochondrial Hsp40, Tid1", Journal of the Korean Magnetic Resonance Society, 22(3), pp.64~70 (2018), 한국자기공명학회[DOI]
- Y. -S. Lee, , J. Mol. Biol, 427, pp.3850~ (2015)
- F. Delaglio, , J. Biomol. NMR, 6, pp.277~ (1995)
- B. A. Johnson, , Methods Mol. Biol, 278, pp.313~ (2004)
- H. C. Kang, , Mol. Cell. Biol, 25, pp.600~ (2005)
- H. C. Kang, , Nucleic Acids Res, 38, pp.5456~ (2010)
- U. Hansen, , Cell Cycle, 8, pp.2146~ (2009)
- S. N. Loh, , Metallomics, 2, pp.442~ (2010)